|
![](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/dot_clear.gif) |
Report to FDA:
![rule](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/blkpixel.gif)
Approved Products
drugs, medical devices, biologicals, animal drugs, food additives
...
Freedom of Information
Dockets Management
FDA Site Map
|
![](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/dot_clear.gif) |
|
![](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/dot_clear.gif) |
Regulations
Current guidance and notices on good clinical practice and
the conduct of clinical trials.
Details about these proposals and instructions
for submitting comments.
Warning letters, disqualification proceedings, restricted list,
adequate assurances list ...
Links to relevant Compliance Program Guidance Manuals and Bioresearch monitoring inspection metrics.
Useful literature references, and training information about good clinical practices.
Redacted GCPP E-mail replies to inquiries that have been submitted by the public to the Good Clinical Practice Program's gcp.questions@fda.hhs.gov E-mail account.
|
![](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/dot_clear.gif) |
![](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/dot_clear.gif) |
|
|
![](https://webarchive.library.unt.edu/web/20090511184934im_/http://www.fda.gov/graphics/dot_clear.gif) |